• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Species-specific activity of antibacterial drug combinations.

Species-specific activity of antibacterial drug combinations.

Details
Files
DOI
10.7892/boris.118551
Publisher DOI
10.1038/s41586-018-0278-9
PubMed ID
29973719
Abstract
The spread of antimicrobial resistance has become a serious public health concern, making once-treatable diseases deadly again and undermining the achievements of modern medicine. Drug combinations can help to fight multi-drug-resistant bacterial infections, yet they are largely unexplored and rarely used in clinics. Here we profile almost 3,000 dose-resolved combinations of antibiotics, human-targeted drugs and food additives in six strains from three Gram-negative pathogens-Escherichia coli, Salmonella enterica serovar Typhimurium and Pseudomonas aeruginosa-to identify general principles for antibacterial drug combinations and understand their potential. Despite the phylogenetic relatedness of the three species, more than 70% of the drug-drug interactions that we detected are species-specific and 20% display strain specificity, revealing a large potential for narrow-spectrum therapies. Overall, antagonisms are more common than synergies and occur almost exclusively between drugs that target different cellular processes, whereas synergies are more conserved and are enriched in drugs that target the same process. We provide mechanistic insights into this dichotomy and further dissect the interactions of the food additive vanillin. Finally, we demonstrate that several synergies are effective against multi-drug-resistant clinical isolates in vitro and during infections of the larvae of the greater wax moth Galleria mellonella, with one reverting resistance to the last-resort antibiotic colistin.
Date Issued
2018-07
Publication Type
Article
Subject(s)
500 Science > 570 Life sciences; biology
600 Technology > 610 Medicine & health
300 Social sciences, sociology & anthropology > 360 Social problems & social services
Language(s)
en
Author(s)
Brochado, Ana Rita
Telzerow, Anja
Bobonis, Jacob
Banzhaf, Manuel
Mateus, André
Selkrig, Joel
Huth, Emily
Bassler, Stefan
Zamarreño Beas, Jordi
Zietek, Matylda
Ng, Natalie
Förster, Sunniva Marita  
Institut für Sozial- und Präventivmedizin (ISPM)  
Institut für Infektionskrankheiten  
Ezraty, Benjamin
Py, Béatrice
Barras, Frédéric
Savitski, Mikhail M
Bork, Peer
Göttig, Stephan
Typas, Athanasios
Additional Credits
Institut für Sozial- und Präventivmedizin (ISPM)  
Institut für Infektionskrankheiten  
Journal
Nature
Publisher
Macmillan Journals Ltd.
ISSN
0028-0836
Access(Rights)
restricted
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: 0eaa7c [ 7.08. 11:06]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • BORIS Portal & Open Science
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo
Repository logo COAR Notify